TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects (TRAMmoniTTR)

October 10, 2023 updated by: CENTOGENE GmbH Rostock

Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol

National, multicenter, epidemiological, longitudinal protocol to investigate the hATTR prevalence in an at-risk population for Hereditary Transthyretin Amyloidosis (hATTR) and subjects diagnosed with hATTR, to monitor the clinical status in TTR positive subjects and to establish hATTR biomarker/s

Study Overview

Detailed Description

Hereditary TransThyRetin Amyloidosis (hATTR) is a slowly progressive condition, that is transmitted as an autosomal dominant trait and is characterized by abnormal extracellular deposits of fibrillar, misfolded proteins (amyloid fibrils) in the body. Amyloid fibrils can be deposited in different body compartments, such as the nerves, heart, gastrointestinal tract, kidneys and brain, causing severe structural changes. More than 30 proteins can trigger the formation of amyloid fibrils, 5 of which can infiltrate the heart and cause cardiac amyloidosis.

One of these amyloidogenic protein is transthyretin, formerly known as prealbumin. Transthyretin (TTR) is found primarily in the serum (secreted by the liver) and cerebrospinal fluid (secreted by the choroid plexus) and functions as a carrier for the hormone thyroxine (T4) and retinol-binding protein (bound to retinol or vitamin A). The destabilization of the TTR protein and the formation of misfolded TTR.

It is the goal of this study to investigate the prevalence of Hereditary Transthyretin-related Amyloidosis (hATTR) in a cohort of 5.000 subjects are at risk for Hereditary Transthyretin Amyloidosis (hATTR) and subjects diagnosed with hATTR, to monitor the clinical status in TTR positive subjects and to establish hATTR biomarker/s.

Study Type

Observational

Enrollment (Estimated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Linz, Austria, 4021
        • Completed
        • Kepler Universitätsklinikum, Klinik für Interne 1 - Kardiologie und internistische Intensivmedizin; Cardiology
      • Linz, Austria, 4021
        • Completed
        • Kepler Universitätsklinikum, Neuromed Campus; Neurology
      • Aachen, Germany, 52074
        • Recruiting
        • Universitätsklinikum Aachen, Neurology
        • Contact:
        • Sub-Investigator:
          • Maike Franziska Dohrn, MD
        • Principal Investigator:
          • Andrea Maier, MD
      • Ahaus, Germany, 48683
        • Recruiting
        • Klinikum Westmünsterland GmbH, I. Medizinische Klinik und Interventionelle Kardiologie
        • Principal Investigator:
          • Alessandro Cuneo, MD
        • Contact:
      • Altenburg, Germany, 04600
        • Recruiting
        • Kreiskrankenhaus Altenburg, Neurology
        • Contact:
        • Principal Investigator:
          • Jörg Berrouschot, MD
      • Arnsdorf, Germany, 01477
        • Completed
        • Sächsisches Krankenhaus Arnsdorf, Akademisches Lehrkrankenhaus der TU Dresden, Neurology
      • Aschaffenburg, Germany, 63739
        • Recruiting
        • Gemeinschaftspraxis Neurologie & Psychiatrie im Stadtpalais
        • Contact:
          • Jochen C. Ulzheimer, MD
          • Phone Number: +49 (0)6021449860
          • Email: j-c-u@gmx.de
        • Principal Investigator:
          • Jochen C. Ulzheimer, MD
      • Bad Nauheim, Germany, 61231
        • Recruiting
        • Kerckhoff-Klinik GmbH, Klinik für Kardiologie, Cardiology
        • Contact:
        • Principal Investigator:
          • Andreas Rieth, MD
      • Bad Neustadt An Der Saale, Germany, 97616
        • Recruiting
        • RHÖN-KLINIKUM Campus Bad Neustadt, Neurology
        • Contact:
        • Principal Investigator:
          • Hassan Soda, MD
      • Berlin, Germany, 10117
        • Recruiting
        • Charité - Universitätsmedizin Berlin Funktionsdiagnostik und Stationen, Cardiology
        • Contact:
        • Principal Investigator:
          • Florian Knebel, MD
      • Berlin, Germany, 10117
        • Recruiting
        • Charité Universitätsmedizin Berlin, Klinik für Neurologie, Neurology
        • Contact:
        • Principal Investigator:
          • Katrin Hahn, MD
      • Berlin, Germany, 13353
        • Recruiting
        • Charité Universitätsmedizin Berlin - Campus Virchow Klinikum (CVK), Cardiology
        • Principal Investigator:
          • Carsten Tschöpe, MD
        • Contact:
      • Bielefeld, Germany, 33604
        • Recruiting
        • Klinikum Bielefeld, Klinik für Kardiologie und internistische Intensivmedizin, Cardiology
        • Contact:
        • Principal Investigator:
          • Christoph Stellbrink, MD
      • Bielefeld, Germany, 33617
        • Recruiting
        • Evangelisches Klinikum Bethel gGmbH v. Bodelschwinghsche Stiftungen Bethel, Neurology
        • Contact:
        • Principal Investigator:
          • Wolf-Rüdiger Schäbitz, MD
      • Bremen, Germany, 28177
        • Completed
        • Klinikum Bremen Mitte gGmbH, Neurologische Klinik, Neurology
      • Bremen, Germany, 28211
        • Recruiting
        • Gesundheit Nord gGmbH - Klinikverband Bremen
        • Contact:
        • Principal Investigator:
          • Thomas Duning, MD
      • Buchholz In Der Nordheide, Germany, 21244
        • Recruiting
        • Krankenhaus Buchholz und Winsen, gemeinnützige GmbH, Cardiology
        • Contact:
        • Principal Investigator:
          • Klaus Hertting, MD
      • Buchholz In Der Nordheide, Germany, 21244
        • Completed
        • Krankenhaus Buchholz und Winsen, gemeinnützige GmbH, Neurology
      • Celle, Germany, 29223
        • Recruiting
        • Allgemeines Krankenhaus Celle, Neurology
        • Contact:
        • Principal Investigator:
          • Ettelt Philipp, MD
      • Cottbus, Germany, 03048
        • Recruiting
        • Carl-Thiem-Klinikum Cottbus gGmbH
        • Contact:
        • Principal Investigator:
          • Alexander Dressel, MD
      • Datteln, Germany, 45711
        • Recruiting
        • St. Vincenz Krankenhaus Datteln, Medizinische Klinik II, Cardiology
        • Contact:
        • Principal Investigator:
          • Marcus Bauer, MD
      • Dortmund, Germany, 44137
        • Recruiting
        • Klinikum Dortmund gGmbH,Stroke-Unit und Neurologische Intensivstation, Neurology
        • Contact:
        • Principal Investigator:
          • Gernot Reimann, MD
      • Düsseldorf, Germany, 40629
        • Recruiting
        • LVR Klinikum Düsseldorf, Neurology
        • Contact:
        • Principal Investigator:
          • Rüdiger Seitz, MD
      • Eberswalde, Germany, 16225
        • Completed
        • Martin Gropius Krankenhaus, Klinik für Neurologie, Neurology
      • Erlangen, Germany, 91045
        • Recruiting
        • Universitätsklinikum Erlangen, Cardiology
        • Contact:
        • Principal Investigator:
          • Steffan Achenbach, MD
      • Essen, Germany, 45138
        • Recruiting
        • Contilia Herz- und Gefäßzentrum, Elisabeth-Krankenhaus Essen, Cardiology
        • Contact:
        • Principal Investigator:
          • Robert Schueler, MD
      • Essen, Germany, 45131
        • Completed
        • Alfried Krupp Krankenhaus Rüttenscheid, Neurology
      • Friedberg, Germany, 86316
        • Completed
        • Kliniken an der Paar Friedberg Krankenhaus, Cardiology
      • Fulda, Germany, 36043
        • Recruiting
        • Herz-Thorax-Zentrum Fulda, Klinikum Fulda gAG, Universitätsmedizin Marburg - Campus Fulda, Cardiology
        • Contact:
        • Principal Investigator:
          • Volker Schächinger, MD
      • Giessen, Germany, D-35385
        • Recruiting
        • University of Giessen-Marburg, Neurology
        • Contact:
        • Principal Investigator:
          • Manfred Kaps, MD
      • Greifswald, Germany, 17489
        • Completed
        • Universitätsklinikum Greifswald der Ernst-Moritz-Arndt-Universität, Neurology
      • Göttingen, Germany, 37075
        • Recruiting
        • Universitätsmedizin Göttingen - Herzzentrum; Cardiology
        • Contact:
        • Principal Investigator:
          • Frauke Czepluch, MD
      • Haar, Germany, 85540
        • Completed
        • kbo-Isar-Amper-Klinikum München-Ost, Klinik für Neurologie, Neurology
      • Halle (Saale), Germany, 06120
        • Recruiting
        • Martin-Luther-Universität, Universitätsklinik und Poliklinik für Neurologie, Neurology
        • Contact:
        • Principal Investigator:
          • Bernhard Sehm, MD
      • Halle (Saale), Germany, 06120
        • Recruiting
        • Universitätsklinik und Poliklinik für Innere Medizin III, Cardiology
        • Contact:
        • Principal Investigator:
          • Alexander Vogt, MD
      • Hamburg, Germany, 20099
        • Completed
        • Asklepios Klinik St. Georg, Klinik für Neurologie
      • Hamburg, Germany, 20246
        • Recruiting
        • Universitäres Herzzentrum Hamburg, Klinik für Allgemeine und Interventionelle Kardiologie, Universitätsklinikum Hamburg-Eppendorf, Cardiology
        • Contact:
          • Monica Patten-Hamel, MD
          • Phone Number: +49 (0)40741057975
          • Email: patten@uke.de
        • Principal Investigator:
          • Monica Patten-Hamel, MD
      • Hamburg, Germany, 22457
        • Recruiting
        • Albertinen-Krankenhaus, Cardiology
        • Contact:
        • Principal Investigator:
          • Herbert Naegele, MD
      • Hamburg, Germany, 20354
        • Completed
        • Neurologie Neuer Wall, Fachärzte für Neurologie & Psychiatrie, Neurology
      • Hamburg, Germany, 22763
        • Completed
        • Asklepios Klinik Altona, Neurologische Abteilung mit überregionaler Stroke Unit, Neurophysiologie und Neurologischer Intensivmedizin
      • Hannover, Germany, 30625
        • Recruiting
        • Medizinische Hochschule Hannover, Klinik für Neurologie; Neurology
        • Contact:
        • Principal Investigator:
          • Thomas Skripuletz, MD
      • Heidelberg, Germany, 69120
        • Recruiting
        • Universitätsklinikum Heidelberg, Klinik für Kardiologie, Angiologie und Pneumologie, Cardiology
        • Contact:
        • Principal Investigator:
          • Fabian aus dem Siepen, MD
      • Hoyerswerda, Germany, 02977
        • Completed
        • Lausitzer Seenland Klinikum GmbH, Klinik für Neurologie, Neurology
      • Jena, Germany, 07740
        • Recruiting
        • Universitätsklinikum Jena, Neurology
        • Contact:
        • Principal Investigator:
          • Otto W. Witte, MD
      • Kassel, Germany, 34121
        • Completed
        • DRK-Kliniken Nordhessen gGmbH , Klinik für Neurologie und Klinische Neurophysiologie, Neurology
      • Krefeld, Germany, 47805
        • Completed
        • Alexianer Krefeld GmbH, Krankenhaus Maria Hilf, Neurology
      • Leipzig, Germany, 04103
        • Recruiting
        • Universitaetsklinikum Leipzig, Neurology
        • Contact:
        • Principal Investigator:
          • Petra Baum, MD
      • Leipzig, Germany, 04129
        • Recruiting
        • Klinikum St. Georg gGmbH
        • Contact:
        • Principal Investigator:
          • Ilka Schneider, MD
      • Lübben, Germany, 15907
        • Completed
        • Asklepios Fachklinikum Lübben, Neurology
      • Lübeck, Germany, 23538
        • Recruiting
        • Universitäres Herzzentrum Lübeck, Medizinische Klinik II
        • Contact:
        • Principal Investigator:
          • Tobias Graf, MD
      • Lübeck, Germany, 23560
        • Recruiting
        • Sana Kliniken Lübeck GmbH, Medizinische Klinik II
        • Contact:
        • Principal Investigator:
          • Joachim Weil, MD
      • Mainz, Germany, 55131
        • Completed
        • DRK Schmerz-Zentrum, Neurology
      • Mainz, Germany
        • Recruiting
        • Johannes Gutenberg-Universität Mainz, Klinik und Poliklinik für Neurologie; Neurology
        • Contact:
        • Principal Investigator:
          • Frank Birklein, MD
      • Mannheim, Germany, 68163
        • Completed
        • Diakonissen Speyer-Mannheim, Diakonissenkrankenhaus Mannheim, Neurology
      • Mosbach, Germany, 74821
        • Recruiting
        • Neckar-Odenwald Kliniken gGmbH, Kreiskrankenhaus Mosbach, Kardiologie der Klinik für Innere Medizin
        • Contact:
        • Principal Investigator:
          • Peter Oberst, MD
      • Mühlhausen, Germany, 99974
        • Completed
        • Ökumenisches Hainich Klinikum gGmbH, Neurology
      • München, Germany, 80336
        • Recruiting
        • Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, Neurology
        • Contact:
        • Principal Investigator:
          • Beate Schlotter-Weigel, MD
      • München, Germany, 80939
        • Recruiting
        • Kardiologie München Nord, Cardiology
        • Contact:
        • Principal Investigator:
          • Hans Ullrich Ebersberger, MD
      • München, Germany, 81377
        • Recruiting
        • Ludwig-Maximilians-Universität München, Klinikum Großhadern, Neurologische Klinik und Poliklinik & Deutsches Schwindel- und Gleichgewichtszentrum DSGZ, Neurology
        • Contact:
        • Principal Investigator:
          • Florian Schöberl, MD
      • München, Germany, 81675
        • Recruiting
        • Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München
        • Contact:
        • Contact:
        • Principal Investigator:
          • Achim Berthele, MD
      • München, Germany, 81825
        • Completed
        • Praxis für Neurologie, Neurology
      • Neuruppin, Germany, 16816
        • Completed
        • Ruppiner Kliniken GmbH,Hochschulklinikum der MHB, Neurology
      • Perleberg, Germany, 19348
        • Recruiting
        • Kreiskrankenhaus Prignitz gGmbH, Neurology
        • Contact:
        • Principal Investigator:
          • Marko Petrick, MD
      • Regensburg, Germany, 93049
        • Recruiting
        • Krankenhaus Barmherzige Brüder Regensburg, Klinik für Neurologie, Neurology
        • Contact:
        • Principal Investigator:
          • Lukas Kremmler, MD
      • Regensburg, Germany, 93053
        • Recruiting
        • Universitätsklinikum Regensburg, Cardiology
        • Contact:
        • Principal Investigator:
          • Bernhard Unsöld, MD
      • Sande, Germany, 26452
        • Completed
        • Nordwest-Krankenhaus Sanderbusch gGmbH, Neurologische Klinik, Neurology
      • Schkeuditz, Germany, 04435
        • Recruiting
        • Sächsisches Krankenhaus Altscherbitz, Neurology
        • Contact:
        • Principal Investigator:
          • Anne-Dorte Sperfeld, MD
      • Siegen, Germany, 57074
        • Recruiting
        • Jung-Stilling Klinikum Siegen, Diakonie Westfalen Süd Neuro, Neurogeriatrie, Neurology
        • Contact:
        • Principal Investigator:
          • Christian Tanislav, MD
      • Stade, Germany, 21682
        • Recruiting
        • Elbe Klinikum Stade
        • Contact:
        • Principal Investigator:
          • Holger Schmidt, MD
      • Teupitz, Germany, 15755
        • Completed
        • Asklepios Fachklinikum Teupitz, Neurology
      • Tübingen, Germany, 72076
        • Recruiting
        • Universitätsklinikum Tübingen, Zentrum für Neurologie
        • Contact:
        • Principal Investigator:
          • Alexander Grimm, MD
      • Ulm, Germany, 89073
        • Recruiting
        • NeuroPoint, Neurology
        • Contact:
        • Principal Investigator:
          • Herbert Schreiber, MD
      • Ulm, Germany, 89081
        • Recruiting
        • University of Ulm, Neurology
        • Contact:
        • Principal Investigator:
          • Albert Ludolph, MD
      • Weimar, Germany, 99425
        • Recruiting
        • Sophien-u.Hufeland-Klinikum, Klinik für Neurologie und Klinische Neurophysiologie, Neurology
        • Contact:
        • Principal Investigator:
          • Rolf Malessa, MD
      • Wermsdorf, Germany, 04779
        • Recruiting
        • Fachkrankenhaus Hubertusburg gGmbH, Neurologische Klinik, Neurology
        • Contact:
        • Principal Investigator:
          • Adrian Trommer, MD
      • Wismar, Germany, 23966
        • Recruiting
        • Sana HANSE Klinikum Wismar, Klinik für Neurologie, Neurology
        • Contact:
        • Principal Investigator:
          • Sabine Mehnert, MD
      • Wolfratshausen, Germany, v
        • Completed
        • Praxis für Neurologie, Neurology
      • Luzern, Switzerland, 6000
        • Completed
        • Luzerner Kantonspital, Cardiology
      • Olten, Switzerland, 4500
        • Completed
        • Solothurner Spitäler AG, Bürgerspital Solothurn, Cardiology
      • Zug, Switzerland, 6300
        • Completed
        • Praxisgemeinschaft für Kardiologie, Innere Medizin und Psychosomatische Medizin, Cardiology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Participants at risk for Hereditary Transthyretin Amyloidosis (hATTR) and participants diagnosed with hATTR

Description

Inclusion Criteria:

  • Informed consent is obtained from the participant
  • The participant is 18 years of age or older
  • The participant has no diagnosis of alcoholism according to international guidelines
  • The participant has not undergone chemotherapy for any carcinoma

AND

The participant is at risk for hATTR due to two or more the factors listed below:

  • cardiomyopathy or polyneuropathy with no obvious etiology atypical Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) or Motor Neuron Disease (MND)
  • autonomic dysfunction
  • hypertrophic cardiomyopathy or heart failure with preserved ejection fraction Left Ventricular Hypertrophy (LVH)
  • bilateral carpal tunnel syndrome
  • spinal stenosis or spinal radiculopathy
  • gait disorders
  • ocular changes involving vitreous opacities
  • unexplained weight loss >5kg
  • renal abnormalities
  • family history of hATTR
  • based on imaging or biopsy suspected for the wild type TTR (ATTR) and not genetically tested for hATTR

OR • The participant is diagnosed with hATTR

OR

• The participant is a 1st or 2nd degree relative of the TTR positive subject

Exclusion Criteria

  • Informed consent is not obtained from the participant
  • The participant is younger than 18 years of age
  • The participant has a diagnosis of alcoholism according to International guidelines
  • The participant has undergone chemotherapy for any carcinoma
  • The participant is not at risk for hATTR

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Participants at risk for hATTR and participants diagnosed with hATTR
Participants 18 years of age or older

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analysis of prevalance of hATTR mutations among a cohort of participants at risk for hATTR.
Time Frame: 4 years
DBS-based genetic analyses of TTR gene will be perfomed via the combination of the Next-Generation Sequencing (the mutation will be confirmed by Sanger sequencing) and the Multiplex ligation-dependent probe amplification.
4 years
To monitor clinical status in TTR positive subjects.
Time Frame: 4 years
8 Follow up visits within 24 months
4 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Establishment of biomarker/s in TTR positive cohort.
Time Frame: 4 years
hATTR-positive samples will be analyzed for the identification of potential biomarkers (based on MS/MS-Tandem spectroscopy) and compared with the merged control samples in order establish a HAE specific biomarker.
4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Peter Bauer, Prof., CENTOGENE GmbH

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2017

Primary Completion (Estimated)

April 30, 2025

Study Completion (Estimated)

April 30, 2025

Study Registration Dates

First Submitted

July 31, 2017

First Submitted That Met QC Criteria

July 31, 2017

First Posted (Actual)

August 2, 2017

Study Record Updates

Last Update Posted (Actual)

October 11, 2023

Last Update Submitted That Met QC Criteria

October 10, 2023

Last Verified

September 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiomyopathies

3
Subscribe